Company / EPS (Diluted)
ARVINAS, INC. EPS (Diluted) History
FY2018-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest EPS (Diluted)
-$6.62
FY2025
5-year range
-$6.62 / -$2.13
FY2021-FY2025
Trend
-24.7%
vs FY2024
Sector context
#191 of 204
Health Care
What the data says
Among 204 Health Care companies, ARVINAS, INC. is in the bottom 6% for eps (diluted). EPS (Diluted) has declined for 4 consecutive years, from $-2.13 in FY2021 to $-6.62 in FY2025.
Based on SEC 10-K filings.
-6.62 in FY2025.
Declined from $-3.82 to $-6.62 over the past 2 years.
Health Care sector context is included.
EPS (Diluted) over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom 6% in Health CareTop 94% of 204This company -$6.62 Sector average -$0.89
▼
-647.0% below sector average
Key checks
Key Insights
- ARVINAS, INC.'s eps (diluted) has declined for 4 consecutive years.
- In FY2025, eps (diluted) decreased 24.7% year-over-year.
- Ranks #191 out of 204 companies in the Health Care sector.
- Peak eps (diluted) was recorded in FY2021.
Company context
Key Data Points
- Altman Z-Score -0.85 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | EPS (Diluted)Value | YoY GrowthYoY |
|---|---|---|
| FY2025 | -$6.62 | -24.7% |
| FY2024 | -$5.31 | -39.0% |
| FY2023 | -$3.82 | -26.5% |
| FY2022 | -$3.02 | -41.8% |
| FY2021 | -$2.13 | +91.6% |
| FY2020 | -$25.45 | +0.0% |
| FY2019 | -$25.45 | -68.8% |
| FY2018 | -$15.08 | - |
| FY2017 | - | - |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026